Scale Up Your Biopharmaceutical Manufacturing
Our cell and gene therapy development center features a process development pilot plant that can be used to scale up the manufacturing of promising cellular and gene therapy products.
The center is designed to help you augment your in-house process development capacities or gain access to facilities so you can bring a greater number of projects from pre-clinical to human trials without having to risk major capital investment or hire additional employees.
A Collaborative Manufacturing Process
The Center is a collaborative facility where technology developers, process developers and members of the biopharmaceutical industry work side by side to address the challenges in cell and gene therapy manufacturing.
Cell and gene therapy development and optimization
Dedicated scientific team with significant experience in the field
Suspension and adherent cell culture capability
Optimization: cell growth, vector selection, yield
R&D process replication with open to closed system transformation and optimization
Downstream purification with QA and QC
- Cell types: T-cells, NK cells, T-NK cells, HEK 293, antigen specific T-cells and others